Favorable long-term follow-up results over six years for response, survival and safety with imatinib mesylate therapy in chronic phase chronic myeloid leukemia post failure of interferon-alpha treatment
Nom du journal : Blood
Année : 2008
Volume : 111
Page de départ : 1039
Page de fin : 1043